Concord Medical (NYSE: CCM) notes Concord Healthcare 2025 annual report on HKEX
Rhea-AI Filing Summary
Concord Medical Services Holdings Limited reported that its subsidiary Concord Healthcare Group Co., Ltd., which is listed on the Main Board of The Stock Exchange of Hong Kong Limited, filed its annual report for the year ended December 31, 2025 on April 15, 2026.
The filing notes that Concord Healthcare’s H shares trade on the HKSE under stock code 2453.HK and that the annual report is available through the HKSE’s hkexnews website.
Positive
- None.
Negative
- None.
Key Figures
Reporting period: Year ended December 31, 2025
Annual report filing date: April 15, 2026
HKSE stock code: 2453.HK
+1 more
4 metrics
Reporting period
Year ended December 31, 2025
Concord Healthcare annual report period
Annual report filing date
April 15, 2026
Concord Healthcare filing on HKSE
HKSE stock code
2453.HK
Concord Healthcare H shares listing
HK listing announcement date
January 9, 2024
Prior listing announcement for H shares
Key Terms
foreign private issuer, Form 20-F, H shares, Main Board, +1 more
5 terms
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Form 20-F regulatory
"whether the registrant files or will file annual reports under cover of Form 20-F"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
Main Board financial
"a company listed on the Main Board of The Stock Exchange of Hong Kong Limited"
The main board is the primary segment of a stock exchange where larger, more established companies are listed under stricter rules and disclosure requirements. For investors it matters because companies on the main board tend to be easier to buy or sell, provide more public information and regulatory oversight, and are generally seen as lower risk than firms on secondary or junior markets—think of a main stage versus a side stage at a concert.
The Stock Exchange of Hong Kong Limited financial
"listed on the Main Board of The Stock Exchange of Hong Kong Limited"
The Stock Exchange of Hong Kong Limited is the main marketplace where shares and other financial instruments are bought and sold in Hong Kong, like a large, organized marketplace that matches people who want to sell ownership in companies with those who want to buy. It matters to investors because it sets the rules for trading, provides price information and liquidity (how easily assets can be bought or sold), and connects local and global capital, which affects the value and accessibility of investments.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Concord Medical Services (CCM) announce in this Form 6-K?
Concord Medical Services announced that its subsidiary, Concord Healthcare Group Co., Ltd., filed its annual report for the year ended December 31, 2025 with the Hong Kong Stock Exchange on April 15, 2026, and that the document is accessible via the HKEX news website.
Who is Concord Healthcare in relation to Concord Medical Services (CCM)?
Concord Healthcare Group Co., Ltd. is a subsidiary of Concord Medical Services Holdings Limited. It is listed on the Main Board of The Stock Exchange of Hong Kong Limited and issues H shares under stock code 2453.HK, with Concord Medical highlighting its annual reporting activity.
When did Concord Healthcare file its annual report for 2025 on the HKSE?
Concord Healthcare filed its annual report for the year ended December 31, 2025 on April 15, 2026. Concord Medical’s Form 6-K simply informs U.S. investors of this Hong Kong filing and points them to the HKEX website for access to the full report.
Where can investors access Concord Healthcare’s 2025 annual report mentioned by CCM?
The annual report is available through the Hong Kong Stock Exchange’s hkexnews website at www.hkexnews.hk. Concord Medical’s Form 6-K directs readers there for detailed information about Concord Healthcare’s 2025 results and disclosures as filed in Hong Kong.